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The Contribution of Individual Exercise
Training Components to Clinical Outcomes
in Randomised Controlled Trials of Cardiac
Rehabilitation: A Systematic Review and
Meta-regression
Bridget Abell* , Paul Glasziou and Tammy Hoffmann
Abstract
Background: While the clinical benefits of exercise-based cardiac rehabilitation are well established, there is
extensive variation in the interventions used within these trials. It is unknown whether variations in individual
components of these exercise interventions provide different relative contributions to overall clinical outcomes.
This study aims to systematically examine the relationship between individual components of the exercise
intervention in cardiac rehabilitation (such as intensity and frequency) and clinical outcomes for people with
coronary heart disease.
Methods: In this systematic review, eligible trials were identified via searches of databases (PubMed, Allied and
Complementary Medicine, EMBASE, PEDro, Science Citation Index Expanded, CINAHL, The Cochrane Library,
SPORTDiscus) from citation tracking and hand-searching. Studies were included if they were randomised trials of a
structured exercise intervention (versus usual care) for participants with coronary heart disease and reported at least
one of cardiovascular mortality, total mortality, myocardial infarction or revascularisation outcomes. Each included
trial was assessed using the Cochrane Risk of Bias Tool. Authors were also contacted for missing intervention details
or data. Random effects meta-analysis was performed to calculate a summary risk ratio (RR) with 95% confidence
interval (CI) for the effect of exercise on outcomes. Random effects meta-regression and subgroup analyses were
conducted to examine the association between pre-specified co-variates (exercise components or trial
characteristics) and each clinical outcome.
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Results: Sixty-nine trials were included, evaluating 72 interventions which differed markedly in terms of exercise
components. Exercise-based cardiac rehabilitation was effective in reducing cardiovascular mortality (RR 0.74, 95% CI
0.65 to 0.86), total mortality (RR 0.90, 95% CI 0.83 to 0.99) and myocardial infarction (RR 0.80, 95% CI 0.70 to 0.92).
This effect generally demonstrated no significant differences across subgroups of patients who received various
types of usual care, more or less than 150 min of exercise per week and of differing cardiac aetiologies. There was
however some heterogeneity observed in the efficacy of cardiac rehabilitation in reducing total mortality based on
the presence of lipid lowering therapy (I2 = 48%, p = 0.15 for subgroup treatment interaction effect). No single
exercise component was identified through meta-regression as a significant predictor of mortality outcomes,
although reductions in both total (RR 0.81, p = 0.042) and cardiovascular mortality (RR 0.72, p = 0.045) were observed
in trials which reported high levels of participant exercise adherence, versus those which reported lower levels. A
dose-response relationship was found between an increasing exercise session time and increasing risk of
myocardial infarction (RR 1.01, p = 0.011) and the highest intensity of exercise prescribed and an increasing risk of
percutaneous coronary intervention (RR 1.05, p = 0.047).
Conclusions: Exercise-based cardiac rehabilitation is effective at reducing important clinical outcomes in patients
with coronary heart disease. While our analysis was constrained by the quality of included trials and missing
information about intervention components, there appears to be little differential effect of variations in exercise
intervention, particularly on mortality outcomes. Given the observed effect between higher adherence and
improved outcomes, it may be more important to provide exercise-based cardiac rehabilitation programs which
focus on achieving increased adherence to the exercise intervention.
Key Points
 Exercise-based cardiac rehabilitation interventions
demonstrate considerable heterogeneity in format,
yet few individual exercise training components
predict better or worse clinical outcomes.
 Adherence to the exercise intervention as prescribed
may however be important in affecting mortality
outcomes.
 Clinicians should be aware that structured exercise
programs can be flexible in design, without greatly
impacting on the clinical outcomes expected.
Background
While ongoing improvements in diagnosis and treatment
have resulted in a steady increase in survival rates from
major coronary events [1, 2], the burden of coronary heart
disease on public health remains a substantial problem.
With an increasing number of patients surviving acute
cardiac events, the impetus to use effective secondary pre-
vention strategies grows. However, this need is not being
met, with up to 40% of all coronary events occurring in pa-
tients who have previously been diagnosed or hospitalised
with the disease [3–5], and well-documented evidence-
practice gaps in the use of effective therapies [6, 7].
Reducing the frequency of these recurrent events by
enhancing the uptake of effective pharmacological and
non-pharmacological interventions should therefore be
considered an important health care priority.
While the benefits of exercise-based cardiac rehabili-
tation in the secondary prevention of coronary heart
disease are well established [8–10], the complex nature
of this intervention presents a substantial challenge to
its implementation. Individual trial results vary consid-
erably in terms of effectiveness, as well as in the type
and ‘dose’ of exercise intervention provided, making it
difficult to synthesise and translate these findings into
practice in a way which provides optimal patient bene-
fit. This problem has been compounded by incomplete
reporting of intervention details in a substantial pro-
portion of cardiac rehabilitation trials [11, 12]. In turn,
this has hampered past attempts to understand how,
and which, intervention characteristics relate to clinical
outcomes.
Given the substantial variability of interventions in car-
diac rehabilitation trials, it is pertinent to explore whether
the differences in exercise interventions are contributing to
the differences in observed effectiveness. While meta-
analyses of these trials have provided evidence for the over-
all effectiveness of cardiac rehabilitation, vital content
about the individual interventions and their effective com-
ponents had been lost in the process of pooling these stud-
ies. An opportunity exists however to open this ‘black box’
of pooled interventions, by using meta-regression tech-
niques to perform a more robust examination of the key
intervention characteristics which may be associated with
positive clinical outcomes [13, 14]. Past attempts to use this
technique with cardiac rehabilitation have however only
used a crude measure of exercise dose [8, 10, 15], excluded
exercise interventions without a multi-faceted secondary
prevention approach [16] or examined only intermediate
outcomes such as cardiorespiratory fitness [17, 18].
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The aim of this systematic review of randomised
controlled trials of exercise-based cardiac rehabilitation
for patients with coronary heart disease was to use
meta-regression and subgroup meta-analysis to explore
the contribution of individual exercise characteristics to
clinical outcomes. This review expands on previous ana-
lyses by separating the exercise intervention into its
smallest component parts, as well as obtaining and in-
corporating as many details as possible about previously
unpublished intervention characteristics directly from
trial authors.
Methods
Inclusion Criteria
Studies were eligible if they were randomised controlled
trials with at least one arm that compared exercise-based
cardiac rehabilitation to usual care, and which reported at
least one of the following outcomes: total mortality,
cardiovascular mortality, myocardial infarction, coronary
artery bypass graft (CABG) or percutaneous coronary
intervention (PCI). Trial participants could comprise men
or women of any age who had been diagnosed with coron-
ary heart disease, suffered a myocardial infarction, or
undergone either CABG or PCI procedures.
Cardiac rehabilitation could have been provided in any
setting (e.g. home, community or outpatient centre) but
must have involved the prescription of a structured exer-
cise program (either supervised or unsupervised), with
or without the addition of lifestyle modification and
counselling. Unsupervised home-based interventions
were required to comprise a structured and detailed ex-
ercise prescription for participants (e.g. specific intensity,
frequency and duration of individual sessions) with
regular staff review, in a similar manner to centre-based
programs. Including only structured exercise interven-
tions (and excluding those which offered only general
exercise advice, e.g. perform 150 min of exercise per
week, walk daily) allowed for a more robust examination
of the effect of specific exercise variables on outcomes.
Trials with a follow-up period of <3 months, with inad-
equate randomisation techniques, or those reporting on
heart failure programs, were excluded. Trials published in
abstract form only (from conference proceedings) were
eligible for inclusion only if authors responded to email
requests for further study information to determine if they
met all eligibility criteria.
Search Strategy and Selection of Studies
We conducted a structured search (last run on 28 January
2016) of the following databases: PubMed, Allied and
Complementary Medicine, EMBASE, PEDro, Science
Citation Index Expanded (via Web Of Science), CINAHL,
The Cochrane Library and SPORTDiscus. The search
strategy was developed in conjunction with an
experienced medical librarian, consisted of a variety
of exercise-based rehabilitation terms combined with
coronary heart disease descriptors and used methodological
filters to limit the results to randomised controlled trials,
meta-analyses and systematic reviews. Variations of the fol-
lowing were searched, using a combination of text words
and index terms: coronary artery disease, ischemic heart
disease, cardiovascular disease, myocardial infarction, an-
gina, CABG, PTCA, rehabilitation, cardiac rehabilitation,
exercise, physiotherapy, physical fitness, exercise training,
training program, aerobic exercise, randomised controlled
trial, random, controlled trial, meta analysis, systematic
review and clinical trial (Additional file 1: Appendix S1
contains full search strategy).
In order to identify further trials, the reference lists of
all eligible studies were hand-searched, as well as those of
previously published cardiac rehabilitation meta-analyses
and systematic reviews. The process was supplemented
further with searches of conference proceedings in the
field from the previous 2 years (World Congress of Cardi-
ology, American Heart Association Scientific Sessions,
European Society of Cardiology Congress and EuroPre-
vent), and by forward and backward citation tracking of
all eligible studies in Web of Science. No restrictions were
placed on language or date of publication.
The titles and abstracts of all articles retrieved from
electronic searching and other sources were screened
(by BA) for eligibility against the pre-specified inclusion
criteria, and full-text publications were obtained for any
potentially relevant studies. Any uncertainties regarding
study eligibility were resolved through discussion with
two other reviewers (PG, TH) until a consensus was
reached.
Data Extraction
A standardised data extraction form (available on request)
was used to extract the following: participant characteris-
tics (gender, age, diagnosis), intervention(s) characteristics,
follow-up duration, all relevant clinical outcomes re-
ported, the type of care provided to the usual care
comparison group, cardiovascular medication usage and
details about the methodological quality of the trial. If
multiple time points were reported, data from all which
were greater than 3 months were extracted. Where
multiple intervention arms were compared with usual care
within a single study, each exercise arm was considered a
separate intervention and data extracted accordingly.
In order to extract the individual exercise characteristics
(used as co-variates in meta-regression analysis) from each
included intervention in a standardised manner, a modi-
fied version of the Template for Intervention Description
and Replication checklist was used [19] (Additional file 1:
Table S2). Where the individual components of exercise
interventions were missing or described in insufficient
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detail, attempts were made to locate this information
in additional publications or by contacting each corre-
sponding author (n = 62) via email. This process is
described in further detail elsewhere [11]. While 28
authors responded to these requests and provided missing
intervention details, 14 did not respond to numerous
reminders. We were unable to locate contact details for a
further 20 authors. A number of authors were also
contacted to clarify outcome data.
Outcomes
Our primary outcome was cardiovascular mortality.
Secondary outcomes were total mortality, myocardial in-
farction, CABG and PCI procedures. All outcomes were
assessed for the time period beginning with randomisa-
tion until the end of last reported follow-up, thereby in-
cluding events which occurred before, during and after
the exercise intervention period for all trials. We chose
not to use a combined endpoint for analysis, as although
it may have increased the statistical power required to
detect treatment effects, it can also be problematic in
interpretation and generate misleading conclusions,
particularly about the strength of reductions in mortality
[20, 21]. For this reason, the results of each outcome are
presented separately.
Risk of Bias of Included Trials
The quality of each included trial was assessed according
to the Cochrane Risk of Bias Tool [22]. Trials were rated
as having a low, high or unclear risk of bias for the
following criteria: sequence generation (adequate random-
isation methods described), concealment of allocation,
study blinding (of participants, personnel and outcomes),
incomplete outcome data (participant attrition) and select-
ive outcome reporting. Blinding of participants to exercise
interventions is virtually impossible; however, the clinical
outcomes in our analyses are unlikely to be influenced by
knowledge of group allocation. We therefore considered
the criterion of blinding in terms of outcome assessment.
The degree of participant attrition was assessed at the out-
come, rather than the study level. For example, a substan-
tial number of participants may not have completed the
trial (high-risk attrition at study level) but the authors
were able to determine from medical records whether or
not these missing participants were deceased at the trial
end (low-risk attrition for mortality outcome).
Statistical Analysis
Both meta-analysis and meta-regression techniques were
carried out in order to synthesise the individual trial data
for each intervention and then examine the effect of in-
dividual intervention characteristics on each outcome.
All comparisons of exercise-based cardiac rehabilitation
versus usual care are expressed as relative risks (RRs)
with 95% confidence intervals (CI) which were calcu-
lated from reported event and population data in each
trial. Effects were considered statistically significant at a
p value of <0.05. In order to minimise the bias due to
missing participant data across a number of trials, the
primary meta-analysis was conducted using a complete
case analysis, as proposed in the Cochrane Handbook
[23] and by Akl et al. [24]. This method uses, as the
denominator, only those participants with complete out-
come data recorded. Meta-analyses were performed in
RevMan (Version 5.3, Cochrane Collaboration), with the
relative risks of the outcome in each study pooled using
a Mantel-Haenszel random effects model. Both the
meta-analysis and meta-regression were performed using
random effects models as clinical heterogeneity was
expected given the wide variety of interventions and
patients represented in the included trials. We tested for
this heterogeneity in each meta-analysis using the
Cochrane Q statistic and also calculated the I2 to quan-
tify the percentage of variation in effectiveness across
studies which would be considered beyond a chance
finding. Potential for publication bias was examined
using funnel plots.
In trials with multiple intervention arms, combining
these into a single group is the recommended approach
for meta-analysis to avoid unit-of-analysis errors arising
from correlated intervention effects. Using this approach
however does not allow an investigation into the differ-
ences between treatment arms required by this analysis.
Hence, we chose to use another recognised approach,
dividing proportionally the number of events and total
population of the shared usual care group between inter-
vention arm comparisons, avoiding ‘double-counting’
while still allowing exploration of heterogeneity across
differing interventions [23].
We also used approaches proposed by Akl et al. [25]
to test the robustness of effect estimates to missing
participant data (due to withdrawal, drop-out, etc.).
This was done by conducting two different sensitivity
analyses using plausible assumptions to impute missing
participant event data for each trial. The first assumed
that the incidence of events in all missing participants
was the same as that observed among those followed
up in the control arm of the same trial. The second
approach imputed missing participant data relative to
those with complete data in the same trial arm, assum-
ing that those missing in the intervention arm had an
increased event incidence of 1.5 compared to those
followed up, and the control arm the same event inci-
dence (1.0) in those with complete and missing data.
We additionally performed further sensitivity analyses
excluding those trials assessed at high risk of bias for
missing outcome data and those published in only
abstract form or as a doctoral thesis.
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Subgroup Analyses
We conducted subgroup analyses to investigate differ-
ences in each outcome for four broad cardiac rehabilita-
tion program comparisons which were specified a priori,
based on issues raised in previous research or due to
current guideline recommendations for cardiac rehabili-
tation and physical activity. These comparisons were (1)
trials which enrolled only patients with a diagnosis of
myocardial infarction vs those with mixed aetiologies
[13]; (2) programs which contained ≥150 min of pre-
scribed weekly exercise vs those with <150 min per week
[26, 27]; (3) programs with a more intensive usual care
arm vs programs with a standard usual care arm [12, 28];
and (4) programs that included lipid lowering statin ther-
apy vs those that did not [13, 29]. Information about the
concomitant use of lipid lowering therapy in each trial
arm was extracted directly from studies where possible.
Where this was not reported, we used the recruitment
dates and duration of follow-up of participants to ascer-
tain if statin use was likely, based on increasing clinical
use from 1994 [30]. All subgroup differences were tested
for significance using RevMan, and an I2 statistic was also
computed in order to estimate the degree of subgroup
variability due to true differences rather than chance.
Meta-regression
The effect of individual exercise intervention character-
istics on both primary and secondary outcomes was
explored by using the ‘metareg’ command in Stata
(Version 14, StataCorp LP) [31] to perform univariate
random effects meta-regression. The median year of trial
recruitment and pre-specified exercise program charac-
teristics of intervention duration (months), exercise in-
tensity (%HRmax), session frequency (times per week),
session time (minutes), intervention provider (physician
in team vs not), mode of exercise (aerobic only vs
aerobic plus resistance training), delivery of exercise
(group vs individual) and level of adherence to the pre-
scribed exercise regimen (modelled as a categorical vari-
able) were entered as co-variates. Adherence was
extracted as the mean proportion of all prescribed centre
and/or home-based exercise sessions completed by
participants. We used established equations and tables
[32, 33] to convert exercise intensities reported in vary-
ing formats across studies (e.g. Borg scale, % heart rate
reserve, % VO2max) into one consistent format (% maximal
heart rate) for all analyses.
Co-variates were considered statistically significant
predictors of outcome if the p value associated with the
RR of the meta-regression was <0.05. Multiple testing
was accounted for by using the ‘permute 5000’ option in
Stata to examine any variables which reached statistical
significance [31]. R2 was calculated to explain the
percentage of between study variance explained by any
particular co-variate. To assess whether any characteris-
tics which displayed statistical significance in univariate
analysis were independently associated with improved
outcomes, we combined any co-variates with a p value
of ≤0.2 in a multivariable model and used a stepwise
backwards elimination approach to remove those which
did not contribute significantly to the model.
Results
Trial Selection
Sixty-eight publications [34–101] met our inclusion
criteria (see Fig. 1 for PRISMA flow chart), reporting
on clinical outcomes and follow-up of 69 different
trials (one publication [98] reported outcomes of a
collaborative study which involved several individual
trial centres). Several trials included multiple inter-
vention arms [39, 71, 72, 87] resulting in a total of
72 individual exercise interventions.
Trial Characteristics
Of the included 69 trials (characteristics described in
Table 1), one was only reported in abstract form (for
which the author provided data), one was a published
doctoral thesis and the remainder were full-text publica-
tions. Most (65) were published in English, with one each
in Italian and Danish and two in Russian (all of which
were translated for inclusion). Publication years ranged
from 1975 to 2015, and the majority of trials (59%) took
place in Europe. Trial size varied from 28 to 1813 partici-
pants; however, most were small, with a median of 134
participants. The median duration of follow-up across all
trials was 3 years but varied widely: the longest follow-up
reported for mortality outcomes was 19 years and for
myocardial infarction, CABG and PCI 10 years.
Participant Characteristics
Of the 13,423 participants with coronary heart disease in-
cluded in all trials, the mean age in individual trials ranged
from 49 to 80 years, with an average age of 54 years
(Table 1). The majority of participants were male (83%),
with only 10 trials containing more than 25% of female
participants and 26 trials (38%) comprising male partici-
pants only. A large proportion of trials (43/69; 62%) in-
cluded only patients after myocardial infarction; however,
those published from 1990 onward often included patients
diagnosed with coronary artery disease (n = 8; 12%), post-
PCI (n = 5; 7%), post-CABG (n = 2; 3%) or a combination
of these cardiac aetiologies (n = 11; 16%).
Intervention Characteristics
Despite our repeated attempts to obtain missing infor-
mation [11], many details about the individual compo-
nents of exercise interventions remained unknown, with
22% of interventions with missing details for at least one
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characteristic of session time, session frequency or exer-
cise intensity. Hence, while these trials and interventions
are included in the overall meta-analysis, they could not
be entered into the meta-regression where these co-
variates were missing.
What, How, Where and Who Details of the Interventions
An overview of the main details of each intervention is pro-
vided in Table 1. Exercise training was conducted in super-
vised outpatient, residential or community-based settings in
the majority of interventions, with only 18% (n = 13)
containing sessions which were conducted entirely in an
unsupervised, home-based environment. Consequently,
most interventions also used some form of group exercise
training (80%; n = 53; six missing details). All 72 interven-
tions used aerobic exercise training, with 54% (n = 31; 15
missing) also containing resistance training or callisthenic
body-weight exercises. Interval training was used in eight
interventions and circuit-based exercises in seven, while six
interventions consisted only of home-based walking
programs. In 53 (74%) interventions, exercise was com-
bined with other secondary prevention strategies such
as risk factor education, counselling and stress manage-
ment, while the remainder provided exercise training as
a standalone intervention. Allied health staff, such as
physiotherapists and exercise specialists, were directly
involved in the prescription and supervision of exercise
training in more than half of all interventions (n = 32;
59%; 18 missing details), with a physician routinely con-
tributing to exercise supervision in 16 interventions.
Prescribed Exercise Intervention Dose, Intensity and
Adherence
Across all interventions (missing for 21 interventions),
participants were reported to begin exercise training a
mean of 4.8 weeks (SD 2.8) after the initial diagnosis or
cardiac incident. The prescribed ‘dose’ of exercise training
in these interventions varied widely (Table 2). The median
Fig. 1 PRISMA flow diagram of the screening and selection of trials. a Different type of exercise or surgical intervention as comparator. b We
were unable to assess the eligibility of one trial published as a conference abstract as the author did not respond to repeated email inquiries.
Two other conference abstracts described trials with outcomes eligible for inclusion; however, these could not be included as authors were not
yet ready to share their results. One further abstract was eligible for inclusion; however, the author failed to respond to requests for data (abstract
references in Additional file 1: Appendix S3). c One of these trials was later excluded and one included. CAD coronary artery disease, RCT
randomised controlled trial
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duration of exercise interventions was 3 months; however,
the shortest intervention lasted 3 weeks and one contin-
ued for 6 years. Exercise sessions occurred at a median
frequency of three times per week, lasting a mean of
49 min (SD = 19) including warm-up and cooldown. The
combination of prescribed session duration and frequency
in individual interventions exceeded the guideline recom-
mendation of 150 min of exercise per week in 67% of
interventions (n = 38; 16 missing), with the structure of 18
interventions providing <150 min of exercise per week.
Where reported (n = 51, Table 2), exercise intensity was
most often prescribed using a target range, rather than a
single value for the level of effort required. Given the
range of prescribed intensities within a single intervention,
some degree of individualisation is assumed, along with
differing rates of progression to the top of the prescribed
range. This range was most commonly based on a
percentage of the actual peak heart rate achieved during
symptom-limited maximal exercise testing; however, in
four cases, it was based on an age-predicted maximal
heart rate. We also noted exercise intensity prescribed in
several other formats including the Borg scale (n = 6),
METs (n = 1), or peak VO2 (n = 3) or work capacity (n = 1)
measured during symptom-limited exercise testing. Once
converted to the same scale, the mean minimum exercise
intensity prescribed across all interventions was 68% of
the maximal heart rate, increasing up to a mean of 80% at
the top of the prescribed range. Overall, the majority of
interventions prescribed levels of exercise which could be
classified as either moderate-to-vigorous (n = 6; 12%),
vigorous (n = 28; 55%) or vigorous-to-high (n = 5; 10%) in
intensity [33]. Interventions prescribing interval training
generally took the format of vigorous (rather than high
or maximal) intervals lasting 3–4 min interspersed with
2–3 min of active or passive recovery (refer to Table 2
footnotes for details).
Adherence to the prescribed exercise regimen was re-
ported for 46 interventions, and ranged from 60–100%.
For supervised interventions (n = 42), this information
was routinely collected by program or trial staff based on
attendance, while unsupervised interventions (n = 4) relied
on self-reported participant exercise logs, or data collected
via the phone each week. Almost three quarters of inter-
ventions (n = 33) reported levels of adherence which we
classified as high (≥75% all prescribed exercise sessions
completed), with the remainder displaying moderate
adherence levels (50–74% of sessions completed).
Usual Care Comparisons
The care provided in the usual care arm of trials varied
greatly (Table 1). For many comparisons (n = 31; 41%),
the exact nature of care received in this arm was
unspecified, described only as usual care in the hands of
a physician or local health service. Participants in the
control arm of 10 other comparisons were reported to
receive ‘standard cardiological care’, which usually
consisted of guideline-based treatment, including regular
cardiology or nursing review, and medication titration.
The remaining 31 control comparison groups also re-
ceived either usual or cardiological care, with the
addition of risk factor and/or general physical activity
advice (e.g. eat less fat, walk daily). Unlike home-based
intervention arms, these control arm interventions did
not take the form of a prescribed and structured program
but consisted of printed or on-line material, a single edu-
cation session, face-to-face discussion or personalised
advice. The first two types of control arms were classified
as ‘usual care’ in this review, whereas we considered par-
ticipants in the latter type of trials to have been delivered
‘usual care plus lifestyle advice’ in the control arm.
Guideline-based medication regimens which included
statin therapy were reportedly used at baseline, during
the trial, or throughout follow-up, in 24 (34%) of the
control arm comparisons. In a further seven compari-
sons (10%), statin therapy was not explicitly reported but
probable given the dates of participant recruitment.
Lipid-lowering therapy was either not begun in the con-
trol arm, or reported as not used, in 17 comparisons
(24%) and was unlikely used in a further 24 comparisons
with recruitment and follow-up periods preceding 1994.
Overall, this resulted in statin use in the control arm
(matched with comparable use in the intervention arm)
for 40% of comparisons, 56% of comparisons without
statin use in either arm and three trials [46, 48, 60] in
which the intervention arm included a specific pharma-
cological lipid-lowering strategy compared to the control
arm (Table 1).
Publication Bias and Quality Assessment
Publication Bias
The funnel plot for the primary outcome of cardiovas-
cular mortality did not suggest asymmetry or publica-
tion bias (Additional file 1: Figure S4a). Similarly,
evidence of publication bias was not observed for the
outcomes of total mortality, myocardial infarction or
CABG. The funnel plot for the PCI outcome however
displayed possible asymmetry, suggesting the absence
of small studies with favourable effects from the analysis
(Additional file 1: Figure S4b).
Allocation: Random Sequence Generation and Concealment
The reported methods used for random sequence gener-
ation were considered to be at low risk of selection bias
in 34 trials (49%). One study [59] was rated to be at a
high risk of bias, as while initial randomisation occurred
from all referrals using a number table; when a partici-
pant allocated to the intervention arm was not able to
take part in the treatment clinic, a new patient was
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randomly selected from the referral population to be a
case. In the remaining 34 interventions, while random-
isation was reported, the risk attributable to sequence
generation was unclear due to a lack of information. The
allocation sequence was reported as adequately con-
cealed in only a quarter of trials (n = 17). The remaining
52 trials did not provide enough information to make a
judgment about the risk of bias in this domain.
Blinding: Participants, Personnel, and Outcome Assessment
Due to the inherent nature of exercise training, blinding
of participants and providers to the intervention re-
ceived did not occur in any trial. However, in seven trials
(10%), the outcome assessors were blinded to participant
group, and a further 23 (33%) used methods of outcome
assessment (e.g. medical records, registry data) which
would be unlikely to suffer from bias due to lack of
blinding and we judged these trials to be at low risk of
bias. Whether or not blinding of outcome assessment
occurred or objective data sources were used was
unclear in 36 trials (52%). Three trials which explicitly
stated that the study and outcome assessment were
unblinded were rated at high risk of bias.
Incomplete Outcome Data
In terms of mortality outcomes, 11 trials (16%) did not
account for a loss of participant outcome data exceeding
15% and were consequently rated as at a high risk of at-
trition bias. These trials had a mean of 25% missing data,
with one [79] unable to account for outcomes of almost
50% of randomised participants, who later declined to
consent to study procedures (although this dropout was
equal across both trial arms). In regards to the other
outcomes of myocardial infarction, CABG and PCI, 19%
of trials (n = 13) were rated at high risk of attrition bias.
Overall, poor reporting meant that 86% of trials were
rated as an unclear risk of bias in one or more of the
above domains (Additional file 1: Table S5). Eight trials
(12%) were assessed to be at low risk of bias across all four
domains, while 17 (25%) were rated at high risk of bias for
one or more domains, most usually incomplete outcome
data. Additionally, bias due to selective outcome reporting
could only be assessed for five of the included studies
[55, 71, 75, 81, 101] in which all pre-specified primary
and secondary outcomes in the protocols were reported
in the published trials. Consequently, most information
in this review is from studies rated at unclear risk of bias,
and the proportion of studies at high risk of bias for
missing outcome data needs to be considered when inter-
preting the results (Additional file 1: Figures S5a and S5b).
Primary Outcome: Cardiovascular Mortality
Cardiovascular mortality, reported in 31 trials (compris-
ing 44 different interventions and 6926 participants),
showed a statistically significant reduction with exercise-
based cardiac rehabilitation compared to usual care over
a follow-up period of 10 years in length (RR 0.74, 95% CI
0.65 to 0.86, p < 0.0001) (Fig. 2). When considering follow-
up out to 19 years (additional information provided in two
trials), a smaller reduction in risk was observed (RR 0.82,
95% CI 0.73 to 0.91, p = 0.0004). No evidence of heterogen-
eity was observed in either analysis (I2 = 0%). Sensitivity
analysis also demonstrated the effect estimates to be robust
to missing participant data (Additional file 1: Table S6a)
and publication type (Additional file 1: Table S7a).
Analysis of Intervention Components
Subgroup analyses with interventions stratified based on
population diagnosis (I2 = 0%, p = 0.60 for interaction ef-
fect), minutes of prescribed exercise per week (I2 = 0%,
p = 0.81), type of usual care (I2 = 0%, p = 0.72) or the use
of lipid-lowering therapy (I2 = 0%, p = 0.60) did not
demonstrate any differences in effect on cardiovascular
mortality (Additional file 1: Table S8a).
Univariate meta-regression analysis found no significant
effect of the year of recruitment to the trial, exercise mode
and exercise provider; how the exercise was delivered; or
the prescribed intervention duration, session frequency,
time or intensity on cardiovascular mortality outcomes
(Additional file 1: Table S9a). A significant relationship
was however observed between the level of adherence to
the exercise intervention and cardiovascular mortality
(Fig. 3), with a 28% reduction in relative risk (RR 0.72,
95% CI 0.52–0.99, p = 0.045) observed for those compari-
sons reporting high levels of adherence to the prescribed
exercise intervention compared to those reporting only
moderate levels of adherence. No other co-variates met
the pre-specified p value cut-off for entry into the
multivariate model.
Secondary Outcome: Total Mortality
The pooled meta-analysis found a 10% reduction in over-
all mortality risk with exercise-based cardiac rehabilitation
compared to usual care over a follow-up period of 10 years
(Fig. 4). When extending the follow-up period out to
19 years, no demonstrable reduction in overall mortality
was observed (RR 0.97, 95% CI 0.90 to 1.04, p = 0.37).
These intervention effects were also less robust to miss-
ing data with the sensitivity analysis suggesting a trend
towards non-significance (Additional file 1: Table S6b).
No evidence of heterogeneity was observed in either
analysis (I2 = 0%).
Analysis of Intervention Components
Subgroup analyses with interventions stratified based
on population diagnosis, minutes of prescribed exer-
cise per week and the type of usual care did not dem-
onstrate any differences in effect on total mortality
Abell et al. Sports Medicine - Open  (2017) 3:19 Page 20 of 31
Fig. 2 Forest plot of the effect of exercise-based cardiac rehabilitation (vs usual care) on cardiovascular mortality across all types of interventions,
CI confidence interval, CR cardiac rehabilitation
Fig. 3 Relationship between the reported level of exercise intervention adherence and the relative risk of cardiovascular mortality compared to
usual care. Each intervention is represented by a circle; the size of the circle is proportional to the number of participants undertaking that
intervention. A log RR of >0 represents an increase in risk and <0 a decrease
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(Additional file 1: Table S8b). Moderate heterogeneity
however (I2 = 48%, p = 0.15 for interaction) was observed
among subgroups divided by use of concomitant lipid-
lowering therapy, suggesting this may account for some of
the variability in the effect observed. The trend observed
was for exercise-based cardiac rehabilitation interventions
to have a reduced effect in the presence of lipid-lowering
therapy, although this effect did not reach significance.
Univariate meta-regression analysis found that exercise
adherence was the only co-variate which significantly
predicted total mortality outcomes (Additional file 1:
Table S9b). A 19% reduction in relative risk (RR 0.81,
95% CI 0.66–0.996, p = 0.042) was observed for those
comparisons reporting high levels of adherence to the
prescribed exercise intervention compared to those
reporting only moderate levels of adherence. While several
co-variates met the pre-specified p value cut-off for entry
into the multivariable model, after backwards elimination
of non-significant predictors, only adherence remained.
Secondary Outcome: Myocardial Infarction
Random effects meta-analysis found that exercise-based
cardiac rehabilitation produced a 20% reduction in myo-
cardial infarction events compared to usual care (Fig. 4).
This effect was also robust to missing data and publication
type in sensitivity analysis (Additional file 1: Table S6c;
Additional file 1: Table S7c), and no evidence of
heterogeneity was observed (I2 = 0%).
Analysis of Intervention Components
Subgroup analyses with interventions stratified based on
population diagnosis, minutes of prescribed exercise per
week and type of usual care did not demonstrate any
differences in effect on myocardial infarction events
(Additional file 1: Table S8c). Low to moderate hetero-
geneity (I2 = 33%, p = 0.23 for interaction effect) was ob-
served among subgroups divided by use of concomitant
lipid-lowering therapy, which was largely due to the dif-
ference in effect observed in the subgroup of two trials
providing statin therapy as part of the intervention arm.
Univariate meta-regression analysis found only one
co-variate that significantly predicted myocardial infarc-
tion outcomes (Additional file 1: Table S9c). A signifi-
cant positive relationship was observed between the
total time prescribed for exercise each session and the
risk of myocardial infarction (Fig. 5). That is, for every
1 min increase in time (between 25 and 90 min), the
relative risk of myocardial infarction with the exercise
intervention vs usual care increased by 1%. While several
co-variates met the pre-specified p value cut-off for
entry into the multivariable model, after backwards
elimination of non-significant predictors, only exercise
time remained. Due to a moderate pairwise correlation
Fig. 4 The effect of exercise-based cardiac rehabilitation versus usual care on coronary heart disease outcomes. Diamonds represent the pooled
summary estimate of random effects Mantel-Haenszel meta-analysis for each outcome. CR cardiac rehabilitation, UC usual care
Fig. 5 Relationship between the prescribed time for exercise training each session and the relative risk of myocardial infarction compared to
usual care (p = 0.011). Each intervention is represented by a circle; the size of the circle is proportional to the number of participants undertaking
that intervention. A log RR of >0 represents an increase in risk and <0 a decrease
Abell et al. Sports Medicine - Open  (2017) 3:19 Page 22 of 31
between session time and session frequency (r = −0.512),
some potential multicollinearity may have been observed
between these two co-variates in the multivariable ana-
lysis. However, repeating the analysis accounting for this
fact did not produce different results about potential
predictors of myocardial infarction outcomes.
Secondary Outcome: Coronary Artery Bypass Grafting
Random effects meta-analysis found no demonstrable re-
duction in the number of participants who required coron-
ary artery bypass grafting (CABG) in the exercise-based
cardiac rehabilitation interventions compared to usual care
(Fig. 4). Sensitivity analysis for missing outcome data did
not change this effect estimate (Additional file 1: Table S6d),
and no evidence of heterogeneity was observed (I2 = 0%).
Analysis of Intervention Components
Subgroup analyses with interventions stratified based on
minutes of the prescribed exercise per week, the type of
usual care or the use of lipid-lowering therapy did not find
any differences in effect on the number of CABG proce-
dures performed (Additional file 1: Table S8d). However, a
significant interaction was found between the population
diagnosis and outcome, with exercise interventions under-
taken by participants with mixed aetiologies, demonstrat-
ing a greater reduction in CABG event rate compared to
usual care than those which comprised purely myocardial
infarction patients (p = 0.04, I2 = 76%).
Univariate meta-regression analysis did not find any co-
variates to have an effect on CABG outcomes (Additional
file 1: Table S9d). Prescribed intervention duration was
the only co-variate which met the pre-specified p value
cut-off for entry into the multivariate model; conse-
quently, multivariate meta-regression was not performed
for this outcome.
Secondary Outcome: Percutaneous Coronary Intervention
The pooled meta-analysis found no difference between
exercise-based cardiac rehabilitation and usual care in re-
ducing PCI events (Fig. 4), with some possibly important
heterogeneity observed (I2 = 37%, p = 0.06). Sensitivity
analysis for missing outcome data did not change this
effect estimate or substantially reduce the degree of
heterogeneity (Additional file 1: Table S6e). Excluding trial
data obtained only in abstract form reduced heterogeneity
without substantially changing the effect estimate
(Additional file 1: Table S7d).
Analysis of Intervention Components
Subgroup analyses with interventions stratified based on
population diagnosis, type of usual care or minutes of
prescribed exercise per week did not demonstrate any
differences in effect on the number of PCI procedures
performed (Additional file 1: Table S8e). Some non-
significant heterogeneity (I2 = 21%, p = 0.28) was observed
for subgroups stratified by use of lipid-lowering therapy.
However, stratifying the overall meta-analysis based on
this factor could not account for the overall heterogeneity
observed.
Univariate meta-regression analysis found no significant
effect of the year of recruitment to the trial, exercise
mode, format of exercise training or prescribed interven-
tion duration, session frequency or time on PCI outcomes
(Additional file 1: Table S9e). A significant positive rela-
tionship was however observed between the highest level
of intensity prescribed and the risk of PCI (Fig. 6). That is,
for every 1% increase in maximal heart rate prescribed
(between 60 and 91% HRmax), the relative risk of PCI with
the intervention compared to usual care increased by
5%. Additionally, in interventions where the team provid-
ing exercise training included medical practitioners, as
opposed to nursing or allied health staff alone, the risk
Fig. 6 Relationship between the highest intensity of exercise prescribed (as a percentage of maximal heart rate) and the relative risk of
percutaneous coronary intervention compared to usual care (p = 0.047). Each intervention is represented by a circle; the size of the circle is
proportional to the number of participants undertaking that intervention. A log RR of >0 represents an increase in risk and <0 a decrease. Circles
coloured green represent interventions for which the highest intensity was only prescribed for brief periods during interval training. Circles
coloured purple represent interventions for which the highest intensity was only prescribed during the work periods of circuit training
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of PCI was significantly decreased (RR 0.30, 95% CI
0.14–0.62, p = 0.004). None of the co-variates which met
the pre-specified p value cut-off for entry into the multi-
variate model remained after backwards elimination of
non-significant predictors.
Discussion
This meta-analysis demonstrates exercise-based cardiac
rehabilitation to be effective in reducing total and
cardiovascular mortality, as well as myocardial infarc-
tion, in participants with coronary heart disease. This
effect was largely consistent across subgroups of patients
who received various types of usual care, more or less
than 150 min of exercise per week, and of differing
cardiac aetiologies. Additionally, the effectiveness of car-
diac rehabilitation to reduce PCI procedures displayed
borderline significance, which may be important given
that the funnel plot displayed a possible absence of small
studies reporting positive effects.
While the largest proportion of included trials and in-
terventions remained traditional group-based programs
of supervised aerobic (and often resistance) training, our
review also found an expanding range of interventions
including home walking programs, high-intensity inter-
val training, case management and Internet technologies.
Consequently, the prescribed dose of exercise training
varied widely, with some interventions offering a sub-
stantially greater volume of training than others. How-
ever, we were unable to demonstrate evidence for the
effectiveness of any one specific exercise component,
such as intensity, frequency, session time or type, on re-
ducing mortality outcomes. A relationship was observed
however between increasing levels of adherence to exer-
cise training and a reduction in subsequent mortality. In
contrast, we found a detrimental effect of increasing the
prescribed exercise time and intensity on myocardial
infarction and PCI outcomes respectively.
Overall, the results of our pooled analyses are generally
consistent with previous meta-analyses of exercise-based
cardiac rehabilitation. These studies also found a signifi-
cant reduction in the relative risk of cardiovascular
mortality, with a similar magnitude of effect observed in
the most recent analyses [8, 15], which also included
patients of mixed aetiologies. The inability of cardiac re-
habilitation to significantly reduce the frequency of CABG
and PCI events was also reported in these two earlier
studies. The previously observed effects of cardiac re-
habilitation on myocardial infarction and total mortality
have however been mixed.
While earlier meta-analyses found significant reduc-
tions in total mortality of up to 20–30% [12, 15, 102,
103], the most recent review [8], which represented a
broader range of participants and trials conducted in the
modern treatment era, failed to find such a benefit.
While we observed a significant 10% reduction in total
mortality in our sample, this effect was less robust to
missing data in sensitivity analysis and provides some
evidence to support the hypothesis that the effect of car-
diac rehabilitation on total mortality may be attenuated
when considering a wider range of participants in the
modern treatment era.
Exercise-Based Cardiac Rehabilitation in the Modern
Treatment Era
It has been previously suggested that the benefits of
exercise-based cardiac rehabilitation over usual care may
be incremental in the modern era, with the advent of lipid-
lowering therapy and optimal medical treatment [8, 97].
Previous meta-analyses [8, 10, 15, 102] have examined this
hypothesis with subgroup analysis comparing the out-
comes of trials published before and after 1994/95, with
this date acting as a surrogate for changing practices in
treatment reported after this time [30]. While these studies
found no significant subgroup differences and conse-
quently claimed the benefits of cardiac rehabilitation to be
maintained in the modern era, the use of publication date
in this manner has several limitations. Firstly, it is a crude
measure of when a trial was conducted and may not accur-
ately reflect treatment practices at the time of publication.
Trials with long recruitment and follow-up periods, along
with delays in publication, mean that not all post-1994 tri-
als were necessarily conducted in the modern treatment
era. For example, one trial published in 2002 [68] reported
a 10-year follow-up of patients recruited in 1984 and 1985
and was conducted wholly in the pre-statin era. Addition-
ally, at least one study published post-1995 [37] explicitly
excluded the use of lipid-lowering therapy. Including these
trials in their respective year-based subgroups may not
provide a true reflection of changes in care. Furthermore,
even in the modern treatment era, the level of usual care
provided to the control arm can vary widely, from follow-
up with a physician to educational packages or sessions
and targeted guideline advice about lifestyle modification.
This is an important consideration as Janssen et al. [28]
have previously shown that there may be a dilution of
effectiveness for secondary prevention interventions when
compared to control groups where usual care is optimal.
Therefore, to assess the impact of cardiac rehabilita-
tion treatment in the modern era, we examined the
effects of both usual care and lipid-lowering therapy
separately, as well as performing meta-regression
analysis based on the median year of reported trial
recruitment. Subgroup analysis was not able to repli-
cate the findings of Janssen, with no significant differ-
entiation in the effects of cardiac rehabilitation with
the varying levels of usual care provided. This seems to
support the importance of providing structured exercise
training even in the presence of other lifestyle change
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measures, such as physical activity advice, education or
counselling. This is an important consideration given that
the level of usual care provided in clinical practice may
often be less ideal than that delivered in clinical trials.
While subgroup analysis was not able to display a signifi-
cantly different effect of cardiac rehabilitation in programs
with lipid-lowering therapy compared to those without,
we did observe some evidence that total mortality was less
likely to be reduced by cardiac rehabilitation in the pres-
ence of lipid-lowering therapy. This was more pronounced
when excluding those studies with a specific lipid-
lowering strategy in the intervention arm (p for subgroup
differences = 0.07, I2 = 70%).
While this attenuation of effect may be due to statin
therapy alone, it is more likely confounded by other im-
provements in medical management and patient demo-
graphics in these later trials which included lipid-lowering
therapy. Essentially, as hypothesised, statins may be acting
as a surrogate marker for improved medical management
over time. This argument is in agreement with the most
recent Cochrane review on the topic where a trend was
observed via meta-regression for smaller reductions in
total mortality with cardiac rehabilitation trials published
in more recent years [8]. However, our analysis using a
more clinically meaningful co-variate for trial year found
no trend or significant association between the median
year of participant recruitment to the trial and the subse-
quent risk of mortality. Together, these findings suggest
that while pharmaceuticals may affect the ability of cardiac
rehabilitation to reduce overall mortality to some extent,
the importance of this intervention in reducing clinical
events in the modern treatment era does not appear to be
greatly diminished.
The Impact of Exercise Intervention Characteristics and
Prescribed ‘Dose’
Our findings extend those of previous meta-analyses of
exercise training in cardiac rehabilitation, which have also
found no effect of prescribed exercise dose (reported as
program duration × session time × session frequency) on
clinical outcomes [8, 10, 15]. However, analysing the effect
of exercise interventions based on such a crude overall
measure of ‘dose’ may have acted to mask the effects of
the individual components in these earlier analyses, and
none took into account varying exercise intensities.
Additionally, the level of poor intervention reporting we
observed in the majority of trials would have hampered
the ability of researchers to obtain all three elements
required for the calculation of dose (e.g. the most recent
Cochrane review [8] was only able to examine the effect
of 18 doses of exercise on cardiovascular mortality out of
24 trials). Our use of individual exercise components,
along with efforts to obtain missing descriptions, meant
that we were able to explore a greater range of dose
comparisons in analysis, with increased power to detect a
true effect. The finding that few differences in effect were
present, despite these improvements in methodology,
supports the conclusions of the original meta-analyses.
Additionally, they are consistent with a systematic review
which found no effect of exercise session frequency or
duration on improvements in fitness in cardiac rehabilita-
tion patients [18].
It could be argued that energy expenditure expressed
as either MET-hours or kilocalories would have provided
the most useful measure of exercise dose accounting for
various combinations of intensity, frequency and dur-
ation of exercise sessions prescribed within an interven-
tion. However, the combination of missing intervention
characteristics and a lack of knowledge about baseline
VO2 values in the majority of included trials meant that
we were unable to obtain the necessary information to
calculate energy expenditure within most individual in-
terventions. Consequently, we could not examine the
relationship between this measure of exercise dose and
clinical outcomes. Improving the reporting of interven-
tion characteristics and baseline exercise data in future
trials would help to address this issue.
While meta-regression analyses provide a large amount
of evidence based on indirect comparisons of exercise
training interventions within the cardiac population, rela-
tively few trials exist which provide direct, head-to-head
comparisons of variations in individual exercise compo-
nents. Our findings however are largely in agreement with
this small body of literature which has found no effect of
interventions with differing durations [104], frequencies
[105, 106], session times [107] or proportions of hospital-
based sessions [108–110], on fitness, risk factors or quality
of life. While avoiding the potential aggregation bias of
subgroup analysis and allowing a more robust comparison
of intervention characteristics, these trials are unfortu-
nately limited by short follow-up periods and generally
report only on risk factors or biological parameters,
making it difficult to assess their impact on the long-term
clinical outcomes observed in our analysis.
In our analysis, we did not observe higher intensity
interventions to be any more effective than lower inten-
sity ones in reducing mortality or preventing myocardial
infarction in the long term. This differs to other research
which suggests that increased exercise intensity is an im-
portant factor in achieving superior outcomes in patients
with cardiovascular disease. Systematic reviews have
shown high-intensity interval training (HIIT) to be better
than moderate-intensity continuous exercise training at
improving fitness (VO2 peak) in patients with coronary
heart disease [111, 112] or lifestyle-induced chronic dis-
ease [113]. Increased exercise intensity was also associated
with increased gains in fitness in a recent systematic re-
view [18] and in a large cohort of cardiac rehabilitation
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patients [114]. However, our review included only eight
trials which specifically used interval training protocols,
and the intensities prescribed during work intervals were
generally lower than those observed in the HIIT literature.
Additionally, all trials included in our analysis compared
changes in clinical endpoints rather than fitness. While
cardiorespiratory fitness is recognised as an important
prognostic factor for mortality [115, 116] and is associated
with decreased incidence of myocardial infarction and
revascularisation in patients with CAD [117], a direct link
between exercise intensity and clinical endpoints is yet to
be made, as most trials are limited by short-term follow-
up (4 months or less) and are underpowered to detect
changes in clinical endpoints. One trial which did report
an extended follow-up period of 4 years [118] found no
difference in the rate of recurrent myocardial infarction
(fatal and non-fatal) between patients randomised to low
or high intensity exercise.
We did however observe evidence of a statistically
significant relationship between the highest intensity of
exercise prescribed to participants and an increased risk
of PCI events. While we were unable to find similar
reports of this phenomenon in previous research, one
possible explanation may be that higher intensity exercise
causes higher myocardial oxygen demands (as a result of
increasing heart rate, myocardial contractility, ventricular
work and blood pressure) which if not met, may elicit
myocardial ischaemia not otherwise observable at lower
intensities [119, 120]. If observed, these symptoms may
trigger further examination and invasive intervention,
given that trial participants are reviewed regularly, and
that PCI (like CABG) is a physician-driven endpoint
which may be prone to clinically subjective decisions
[121] (an elective rather than a spontaneous event like
death or infarction). Additionally, PCI (as opposed to
CABG) would most likely be considered the primary
method of revascularisation in this population, given that
most of those enrolled in the trials would be at low subse-
quent cardiovascular risk [122]. It is also important to
note that only three of the trials reporting PCI outcomes
prescribed higher training intensities in an interval format
[75, 89, 95], and it may be that periods of intermittent
recovery (as used in HIIT) are needed to mediate the
potential negative effect of higher intensity exercise.
Why an increase in the risk of MI should occur with
longer prescribed session times is also not clear. One
previous trial in coronary patients has found exercise
durations extended to 60 min blunted the beneficial ef-
fects on antioxidants and vasculature observed with
30 min of training [123]. Conversely, 40 and 60 min of
training have been shown to be equally effective in im-
proving exercise capacity and lipid profile [107]. We did
observe some potential confounding between session
frequency and session time, with longer session times
associated with less frequent exercise sessions. Despite
this, however, session frequency alone was not predictive
of MI outcomes, and the relationship between session
time and myocardial infarction remained after adjusting
for the frequency of sessions. Further investigation of
the impact of session time on MI outcomes may therefore
be warranted.
Exercise Adherence and Mortality
Our finding of improved mortality outcomes with in-
creased adherence to exercise training is supported by a
similar observation in several cohort studies involving
cardiac rehabilitation program attendees. Even when
matched for prognostic factors, users of more cardiac
rehabilitation sessions (≥70%) were less likely to die over
the subsequent 5 years than lower users [124], and
program completers had a reduced risk of death and
hospitalisation than non-completers [125]. Additionally,
Hammill [126] observed what appeared to be a dose-
response gradient between sessions attended and the risk
of myocardial infarction and mortality. Unfortunately, all
these studies may have been subject to confounding if
sicker participants were those who stopped attending
earlier. Additionally, they were all based on adherence to
the standardised US model of 36 supervised on-site
sessions, meaning that outcomes observed may not
necessarily be due to adherence alone, but the extra
volume of training received. Given however that the re-
sults we observed in our study arose from adherence to
programs of varying lengths and types and we found no
effect of other training characteristics on mortality,
adherence alone does appear to be an important factor.
While exercise adherence in itself may be an import-
ant driver behind reduced mortality, our findings could
also be attributed to a phenomenon known as the
‘healthy adherer effect’ [127]. That is, those participants
who complete more exercise sessions are also those who
are more likely to adhere to medication regimens and
perform other healthy lifestyle changes. Consequently,
good exercise adherence could be considered a marker
for adherence to other positive health behaviours which
may also decrease the risk of mortality and clinical
events. This has been previously observed by others,
with increased attendance at on-site cardiac rehabilita-
tion sessions related not only to reductions in all-cause
mortality, re-admissions and major events, but also to
greater improvements in clinical risk profile and secondary
prevention behaviours such as medication and dietary ad-
herence [128, 129]. Additionally, some ‘clustering’ of good
lifestyle behaviours (diet, exercise, smoking cessation) was
observed in survivors of MI, where increased adherence
led to a decrease in mortality, myocardial infarction and
stroke [130]. It could also be postulated however that
cardiac rehabilitation programs in themselves promote
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adherence, by providing a structured learning environment
which offers the frequent contact, skills training and self-
efficacy enhancing care required for successful adherence
[131]. Furthermore, knowledge about personal risk factors
(usually provided at CR sessions) has been shown to cor-
relate to a patient’s ability to achieve treatment goals [132].
Consequently, attending an increasing number of sessions
provides increased chances to gain these skills and know-
ledge. Despite these difficulties in separating out the effect
of exercise adherence, it does appear to play a crucial role
in clinical outcomes, which has important implications for
program design.
Implications for Practice
There is a growing concern that cardiac rehabilitation
needs to be re-engineered for the future, with a de-
creased reliance on traditional models of care [29, 133].
In order to do this, it is essential to understand the
interaction between program components and patient
outcomes to ensure essential elements are retained. In
terms of exercise prescription at least, our findings
appear to align well with the current impetus to provide
flexible, individualised and ‘menu-based’ models of care
tailored to circumstances and individual patient needs
[134, 135]. While a number of the exercise training pro-
grams contained within our meta-regression were those
of the traditional hospital-supervised, moderate-to-
vigorous intensity format, many alternate styles were
also observed. All appeared equally effective in reducing
mortality, and most also in reducing the risk of subse-
quent myocardial infarction. It may be more important
therefore to design exercise programs in whichever
format that may help to promote increase participant
adherence, rather than being only concerned with the
details of specific intervention components.
By considering alternative evidence-based models of
exercise training, and offering flexible program design in
order to increase ongoing adherence to exercise, programs
may also attract an increased number of participants to
their service. While a lack of referral is often cited as a sig-
nificant barrier to the uptake of cardiac rehabilitation,
other well-known barriers include issues with the program
itself such as exercise training location, session availability
or the frequency and duration of attendance required
[133, 136]. Knowledge that program design can be flexible,
without greatly impacting on the clinical outcomes ex-
pected, may help to reassure clinicians when prescribing
exercise training. Additionally, flexibility in design may
overcome the resourcing issues faced by many programs
in the current economic climate [137].
Future Questions
It appears obvious that structured exercise training has
clear benefits over usual care, even when this includes
physical activity advice, yet the question remains as to
the minimal threshold of exercise intensity and volume
to produce these changes. This is a pertinent fact to
consider given the rise of health coaching interventions
in recent years which provide exercise interventions in a
format somewhere between general advice and struc-
tured exercise intervention [138, 139]. Additionally, this
review appears to support the hypothesis that the
threshold for global health benefits may occur at low
levels of intensity in people who are deconditioned. The
minimum intensities in some included trials were lower
than the aerobic intensity threshold for fitness improve-
ments of 45% VO2R/60%HRmax proposed by Swain and
Franklin [140], and consequently, it remains unclear at
what point significant improvements in clinical outcome
fail to occur.
Strengths and Limitations
Our study is strengthened by the use of a broad search
strategy with no limitations imposed on language or date
of publication. We also performed sensitivity analysis to
examine the effects of missing data on all outcomes.
Additionally, by using an exhaustive process to contact
trial authors for missing intervention details, we were
able to provide a more complete picture of exercise
training than has ever been previously examined. Our
analysis contains a wide range of interventions, allowing
a comparison of varying exercise characteristics across a
number of clinical outcomes.
The strength of our findings however is limited by the
quality of the included trials. Due to poor reporting,
many were rated at unclear risk of bias, and missing data
were observed in a number of trials. Importantly, how-
ever, imputation of these missing data in sensitivity ana-
lysis did not significantly change the effect of cardiac
rehabilitation on clinical outcomes. Many intervention
details also remained missing, limiting the amount of
data available to perform meta-regression. In particular,
attempts at multivariable analysis (to account for any
potential confounding due to correlated co-variates)
were limited by the low number of interventions report-
ing all exercise co-variates of interest. It is not clear if
these missing variables would have changed the outcome
of the analysis.
It must also be recognised that the results of subgroup
analyses and meta-regression performed in our study are
subject to the challenges associated with interpreting
complex interventions in such a manner. Separating the
effects of all potential effect modifiers is difficult, par-
ticularly where this information may be unreported or
unaccounted for. It must also be considered that these
component parts alone may not be enough to explain
the power of an intervention. A complex intervention
such as cardiac rehabilitation may be more than the sum
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of its parts, and in reducing it down into these parts, we
may lose the essence of what makes it a successful sys-
tem [141]. The outcomes of such interventions may also
be context-dependant, and it is not yet clear how this
can be accounted for in analyses [142].
Finally, while this review contains a large number of
trials from many countries, two thirds of them are more
than 15 years old, and the majority of participants are
still middle-aged men. Therefore, the generalisability of
these findings to modern cardiac rehabilitation practice
including participants of more varied aetiologies, elderly
patients and women may be somewhat compromised.
Conclusions
This meta-analysis has shown that there is a place for
exercise-based cardiac rehabilitation in the modern treat-
ment of coronary heart disease, particularly where it plays a
role in increasing the use of other secondary prevention
therapies, many of which are currently suboptimal. There is
little differential effect of variations in individual exercise
training components, particularly on mortality outcomes.
For this reason, it may be more important to offer pro-
grams which focus on achieving increased adherence to the
exercise intervention, regardless of what format it may take.
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